Showing results (331-340 of 399) with videos related to

Sort By:
Pageof 40
The Lancet. Healthy Longevity|August 3, 2024
Benefits of population-level interventions for dementia risk factors: an economic modelling study for EnglandNaaheed Mukadam, Robert Anderson, Sebastian Walsh, et al.
The Lancet. Healthy Longevity|August 2, 2024
Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trialJames P Sheppard, Eleanor Temple, Ariel Wang, et al.
The Lancet. Healthy Longevity|June 30, 2024
Obesity and risk of diseases associated with hallmarks of cellular ageing: a multicohort studyMika Kivimäki, Philipp Frank, Jaana Pentti, et al.
The Lancet. Healthy Longevity|January 7, 2023
Cardiovascular mortality in women in their forties after hypertensive disorders of pregnancy in the Netherlands: a national cohort studySophie M Welters, Marjon de Boer, Pim W Teunissen, et al.
The Lancet. Healthy Longevity|May 6, 2022
Injury burden in individuals aged 50 years or older in the Eastern Mediterranean region, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019Samar Al-Hajj, Sarah Farran, Abla M Sibai, et al.
The Lancet. Healthy Longevity|June 28, 2021
Circadian disturbances in Alzheimer's disease progression: a prospective observational cohort study of community-based older adultsPeng Li, Lei Gao, Arlen Gaba, et al.
The Lancet. Healthy Longevity|May 9, 2022
Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort studyMaria Krutikov, Oliver Stirrup, Hadjer Nacer-Laidi, et al.
The Lancet. Healthy Longevity|June 10, 2022
Modifiable traits, healthy behaviours, and leukocyte telomere length: a population-based study in UK BiobankVasiliki Bountziouka, Crispin Musicha, Elias Allara, et al.
The Lancet. Healthy Longevity|June 17, 2022
Correction to Lancet Healthy Longev 2022; 3: e253-62
The Lancet. Healthy Longevity|May 6, 2023
Determinants of humoral and cellular immune responses to three doses of mRNA SARS-CoV-2 vaccines in older adults: a longitudinal cohort studyAnthony Ravussin, Anna Hayman Robertson, Asia-Sophia Wolf, et al.
Pageof 40